Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.

@article{Hsu2010RenalFI,
  title={Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.},
  author={C. B. Hsu and Yi-Hsiang Huang and Chien-Wei Su and Han-Chieh Lin and Jen-Huey Chiang and Pui-Ching Lee and Fa-Yauh Lee and T. W. Huo and S. Daniel Lee},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2010},
  volume={30 1},
  pages={
          77-84
        }
}
BACKGROUND Ascites is often present in patients with hepatocellular carcinoma (HCC) with cirrhosis. Advanced cirrhosis may predispose to renal dysfunction. Acute renal failure (ARF) may occur after transarterial chemoembolization (TACE) for HCC because of radiocontrast agents. This study aimed to investigate the incidence and risk factors of ARF and prognostic predictors in HCC patients with ascites undergoing TACE. METHODS A total of 591 HCC patients receiving TACE were enrolled. RESULTS… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma

  • Hepatology international
  • 2011
VIEW 5 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma.

  • International journal of clinical and experimental pathology
  • 2014
VIEW 2 EXCERPTS
CITES BACKGROUND

Similar Papers